Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Clinical trial NCT06846385 · RECRUITING
Trial details
- NCT number
- NCT06846385
- Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-20
- Primary completion
- 2025-05-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.